Header cover image

Brazilian Pharmaceuticals & Biotech Price disconnect

Results

2

1 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

2 companies

Hypera

Market Cap: R$14.9b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$21.16

7D

-1.4%

1Y

-7.7%

Ouro Fino Saúde Animal Participações

Market Cap: R$1.4b

Engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil.

New

OFSA3

R$26.35

7D

-2.4%

1Y

14.3%